Clinical Trial Update: Phase I Trial of Docetaxel With Perifosine [Phase 1]

View source ↗

Summary

Phase I study assessing the combination of docetaxel and perifosine in patients with neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Neoplasms | Phase 1 | Status: COMPLETED